Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS)
CNY 13.63
(-1.16%)
CNY 13.63
(-1.16%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 904.15 Million CNY | 8.16% |
| 2022 | 773.65 Million CNY | 39.16% |
| 2021 | 555.96 Million CNY | 21.33% |
| 2020 | 458.24 Million CNY | 16.6% |
| 2019 | 393 Million CNY | 7.05% |
| 2018 | 367.13 Million CNY | 15.97% |
| 2017 | 316.58 Million CNY | 5.77% |
| 2016 | 299.31 Million CNY | 5.21% |
| 2015 | 284.49 Million CNY | 41.38% |
| 2014 | 201.22 Million CNY | 2.51% |
| 2013 | 196.29 Million CNY | 12.44% |
| 2012 | 174.57 Million CNY | 20.58% |
| 2011 | 144.78 Million CNY | 15.81% |
| 2010 | 125.02 Million CNY | 22.36% |
| 2009 | 102.17 Million CNY | 4.89% |
| 2008 | 97.41 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 196.58 Million CNY | -13.57% |
| 2024 Q3 | 212.29 Million CNY | 7.89% |
| 2024 Q1 | 227.44 Million CNY | 21.59% |
| 2023 Q2 | 245.69 Million CNY | 4.14% |
| 2023 FY | 836.76 Million CNY | 8.16% |
| 2023 Q3 | 191.38 Million CNY | -22.11% |
| 2023 Q4 | 187.05 Million CNY | -2.26% |
| 2023 Q1 | 235.93 Million CNY | 100.38% |
| 2022 Q1 | 209.94 Million CNY | 39.37% |
| 2022 FY | 773.65 Million CNY | 39.16% |
| 2022 Q4 | 117.74 Million CNY | -36.83% |
| 2022 Q3 | 186.38 Million CNY | -28.2% |
| 2022 Q2 | 259.57 Million CNY | 23.64% |
| 2021 Q2 | 126.76 Million CNY | -8.25% |
| 2021 FY | 555.96 Million CNY | 21.33% |
| 2021 Q3 | 140.4 Million CNY | 10.76% |
| 2021 Q4 | 150.64 Million CNY | 7.29% |
| 2021 Q1 | 138.15 Million CNY | 9.07% |
| 2020 Q1 | 109.9 Million CNY | -15.94% |
| 2020 Q3 | 93.75 Million CNY | -26.71% |
| 2020 Q4 | 126.66 Million CNY | 35.1% |
| 2020 FY | 458.24 Million CNY | 16.6% |
| 2020 Q2 | 127.91 Million CNY | 16.38% |
| 2019 Q1 | 74.79 Million CNY | -33.28% |
| 2019 FY | 393 Million CNY | 7.05% |
| 2019 Q4 | 130.75 Million CNY | 36.9% |
| 2019 Q3 | 95.5 Million CNY | 3.87% |
| 2019 Q2 | 91.95 Million CNY | 22.95% |
| 2018 Q1 | 83.81 Million CNY | 3.86% |
| 2018 FY | 367.13 Million CNY | 15.97% |
| 2018 Q4 | 112.1 Million CNY | 19.0% |
| 2018 Q3 | 94.19 Million CNY | 22.31% |
| 2018 Q2 | 77.01 Million CNY | -8.11% |
| 2017 Q4 | 80.69 Million CNY | -3.51% |
| 2017 Q2 | 78.13 Million CNY | 5.41% |
| 2017 Q1 | 74.12 Million CNY | -24.54% |
| 2017 Q3 | 83.63 Million CNY | 7.04% |
| 2017 FY | 316.58 Million CNY | 5.77% |
| 2016 Q1 | 59.86 Million CNY | -17.18% |
| 2016 FY | 299.31 Million CNY | 5.21% |
| 2016 Q4 | 98.22 Million CNY | 34.57% |
| 2016 Q3 | 72.98 Million CNY | 6.97% |
| 2016 Q2 | 68.23 Million CNY | 13.97% |
| 2015 Q2 | 82.05 Million CNY | 29.37% |
| 2015 Q1 | 63.42 Million CNY | -5.83% |
| 2015 FY | 284.49 Million CNY | 41.38% |
| 2015 Q4 | 72.28 Million CNY | 8.33% |
| 2015 Q3 | 66.72 Million CNY | -18.69% |
| 2014 Q1 | 47.69 Million CNY | 0.72% |
| 2014 FY | 201.22 Million CNY | 2.51% |
| 2014 Q2 | 41.92 Million CNY | -12.09% |
| 2014 Q4 | 67.35 Million CNY | 52.2% |
| 2014 Q3 | 44.25 Million CNY | 5.54% |
| 2013 Q3 | 52.31 Million CNY | 0.0% |
| 2013 FY | 196.29 Million CNY | 12.44% |
| 2013 Q4 | 47.35 Million CNY | -9.49% |
| 2012 FY | 174.57 Million CNY | 20.58% |
| 2011 FY | 144.78 Million CNY | 15.81% |
| 2010 FY | 125.02 Million CNY | 22.36% |
| 2009 FY | 102.17 Million CNY | 4.89% |
| 2008 FY | 97.41 Million CNY | 0.0% |